Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Operations, Basis of Presentation and Consolidation

v3.22.2
Note 1 - Nature of Operations, Basis of Presentation and Consolidation
6 Months Ended
Jun. 30, 2022
Notes to Financial Statements  
Business Description and Basis of Presentation [Text Block]

1. NATURE OF OPERATIONS, BASIS OF PRESENTATION AND CONSOLIDATION

 

Nature of Operations 

 

Natural Health Trends Corp., a Delaware corporation (whether or not including its subsidiaries, the “Company”), is an international direct-selling and e-commerce company. Subsidiaries controlled by the Company sell personal care, wellness, and “quality of life” products under the “NHT Global” brand.

 

The Company’s wholly-owned subsidiaries have an active physical presence in the following markets: the Americas, which consists of the United States, Canada, Cayman Islands, Mexico and Peru; Greater China, which consists of Hong Kong, Taiwan and China; Southeast Asia, which consists of Malaysia, Singapore and Thailand; South Korea; Japan; India; and Europe. The Company also operates in Russia and Kazakhstan through an engagement with a local service provider.

 

Basis of Presentation 

 

The unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. As a result, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information for the interim periods presented. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s 2021 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (SEC) on February 25, 2022.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and all of its wholly-owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation.

 

Net Income Per Common Share

 

Diluted net income per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. The dilutive effect of non-vested restricted stock is reflected by application of the treasury stock method. Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized, if any, is assumed to be used to repurchase shares.

 

The following table illustrates the computation of basic and diluted net income per common share for the periods indicated (in thousands, except per share data):

 

   

Three Months Ended June 30,

 
   

2022

   

2021

 
   

Income (Numerator)

   

Shares (Denominator)

   

Per Share Amount

   

Income (Numerator)

   

Shares (Denominator)

   

Per Share Amount

 

Basic net income per common share:

                                               

Net income available to common stockholders

  $ 183       11,346     $ 0.02     $ 229       10,968     $ 0.02  

Effect of dilutive securities:

                                               

Non-vested restricted stock

          78                     456          

Diluted net income per common share:

                                               

Net income available to common stockholders plus assumed conversions

  $ 183       11,424     $ 0.02     $ 229       11,424     $ 0.02  

 

   

Six Months Ended June 30,

 
   

2022

   

2021

 
   

Income (Numerator)

   

Shares (Denominator)

   

Per Share Amount

   

Income (Numerator)

   

Shares (Denominator)

   

Per Share Amount

 

Basic net income per common share:

                                               

Net income available to common stockholders

  $ 78       11,300     $ 0.01     $ 382       10,921     $ 0.03  

Effect of dilutive securities:

                                               

Non-vested restricted stock

          124                     503          

Diluted net income per common share:

                                               

Net income available to common stockholders plus assumed conversions

  $ 78       11,424     $ 0.01     $ 382       11,424     $ 0.03  

 

Recent Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced an expected credit loss model for the impairment of financial assets measured at amortized cost basis and added Topic 326 to the FASB Accounting Standards Codification (“ASC”). In November 2019, the FASB issued ASU 2019-11, Codification Improvements to Topic 326, Financial Instruments - Credit Losses. The amendments to ASU 2019-11 clarify, correct and make improvements to Topic 326. ASU 2016-13 as well as the updates in ASU 2019-11 are effective for interim and annual periods beginning after December 15, 2022, and early adoption is permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Other recently issued accounting pronouncements did not or are not believed by management to have a material impact on the Company’s present or future financial statements.